At the time of writing, Cg Oncology Inc [CGON] stock is trading at $42.47, down -1.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The CGON shares have gain 1.17% over the last week, with a monthly amount glided 7.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cg Oncology Inc [NASDAQ: CGON] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $90. Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $55. JP Morgan started tracking the stock assigning a Overweight rating and suggested a price target of $41 on May 02, 2025. Scotiabank initiated its recommendation with a Sector Perform and recommended $23 as its price target on April 16, 2025. In a note dated October 24, 2024, UBS initiated an Buy rating and provided a target price of $60 on this stock.
For the past year, the stock price of Cg Oncology Inc fluctuated between $14.80 and $45.56. Currently, Wall Street analysts expect the stock to reach $74.67 within the next 12 months. Cg Oncology Inc [NASDAQ: CGON] shares were valued at $42.47 at the most recent close of the market. An investor can expect a potential return of 75.82% based on the average CGON price forecast.
Analyzing the CGON fundamentals
According to Cg Oncology Inc [NASDAQ:CGON], the company’s sales were 0.55M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at 0.72% with Operating Profit Margin at -285.46%, Pretax Profit Margin comes in at -232.45%, and Net Profit Margin reading is -157.27%. To continue investigating profitability, this company’s Return on Assets is posted at -0.12, Equity is -0.13 and Total Capital is -0.23. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 41.83 points at the first support level, and at 41.18 for the second support level. However, for the 1st resistance point, the stock is sitting at 43.35, and for the 2nd resistance point, it is at 44.22.
Ratios To Look Out For
It is important to note that Cg Oncology Inc [NASDAQ:CGON] has a current ratio of 22.15. As well, the Quick Ratio is 22.15, while the Cash Ratio is 0.48. Considering the valuation of this stock, the price to sales ratio is 5887.69, the price to book ratio is 4.83.
Transactions by insiders
Recent insider trading involved POST LEONARD E, Director, that happened on Oct 13 ’25 when 1000.0 shares were sold. Director, Mulay James completed a deal on Oct 09 ’25 to sell 5903.0 shares. Meanwhile, Director JAMES MULAY bought 6557.0 shares on Oct 09 ’25.
